Product Code: PM3020
The global obsessive compulsive disorder market size is expected to reach USD 1,409.41 million by 2032, according to a new study by Polaris Market Research. The report "Obsessive Compulsion Disorder Market Share, Size, Trends, Industry Analysis Report, By Therapy Type; By Symptom Type; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Treatment, therapies, and innovative treatments, as well as breakthroughs in anti-anxiety, antipsychotic, and antidepressant medicines, are projected to present a variety of potential prospects in the OCD pharmaceuticals market. One of the primary factors driving the growth of the obsessive-compulsive disorder drug market in the next years will be the rising usage of off-label treatments. In addition, rising research on first-in-class peptide therapies and increasing generic approvals will result in significant market demand.
The OCD market is predicted to develop due to the high incidence of OCD and lifestyle changes that cause changes in cognitive processes. According to the International OCD Foundation, about nearly 2-3 Mn individuals in the United States suffer from the condition, it is also estimated almost 500,000 American youngsters have OCD. Many cases of OCD go unreported since many individuals are unaware of the existence of such a disorder.
The Bergen 4- Day Treatment (B4DT) is an exposure-grounded treatment administered over four days. In around 70 cases, B4DT has been demonstrated to promote quick and long-lasting absolution. This offers a foundation for exploration into the cerebral and neurobiological differences associated with remedy response and non-response. The current study will look at long-term changes in cerebral assessment and DNA methylation in B4DT cases, and a subset will also have multimodal brain imaging.
Obsessive Compulsion Disorder Drug Market Report Highlights:
- In 2022, contamination obsessions with compulsions are expected to dominate the worldwide obsessive obsessive-compulsive disorder medication market because of advancements in therapy, therapies, and the launch of innovative treatments.
- The market for online pharmacies is expected to increase significantly. The segmented expansion in the obsessive-compulsive disorder pharmaceuticals market may be ascribed to expanding internet penetration and the number of mobile apps.
- North America is the dominant area, because of favorable government initiatives and increased R&D expenditure by leading market participants.
- The global players include: Abbott, Abbvie Inc, Addex Therapeutics, AstraZeneca, Brainsway, C4X discovery, Eli Lilly and Company, Roche Ltd, Meiji holdings, Merck, Mylan, Novartis, Omeros Corporation, Pfizer, Sanofi, Sellas, and Zydus Cadila.
Polaris Market Research has segmented the obsessive compulsion disorder drug market report based on therapy type, symptoms type, distribution channel, and region:
Obsessive Compulsion Disorder Drug, Therapy Type Outlook (Revenue - USD Million, 2019 - 2032)
- Contamination Obsessions
- Checking Compulsion Obsession
- Without Visible Compulsion
- Symmetry Obsessions with ordering Compulsions
- Hoarding
Obsessive Compulsion Disorder Drug, Symptoms Type Outlook (Revenue - USD Million, 2019 - 2032)
- Cognitive Behavioral Therapy
- Augmentation Therapy
- Aversion Therapy
- Systematic Desensitization
- Others
Obsessive Compulsion Disorder Drug, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)
- Hospital Pharmacy
- Online Pharmacy
- Drug Store
- Retail Pharmacy
Obsessive Compulsion Disorder Drug, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Obsessive Compulsion Disorder Drug Market Insights
- 4.1. Obsessive Compulsion Disorder Drug - Industry Snapshot
- 4.2. Obsessive Compulsion Disorder Drug Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Discovery of new medications to treat obsessive-compulsive disorder
- 4.2.1.2. increased acceptance of off-label medications in conjunction with authorized therapy
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Adverse effects of drugs
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Obsessive Compulsion Disorder Drug Market Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Obsessive Compulsion Disorder Drug Market, by Therapy Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 5.3. Contamination Obsession
- 5.3.1. Global Obsessive Compulsion Disorder Drug Market, by Contamination Obsession, by Region, 2019-2032 (USD Million)
- 5.4. Checking Compulsions
- 5.4.1. Global Obsessive Compulsion Disorder Drug Market, by Checking Compulsions, by Region, 2019-2032 (USD Million)
- 5.5. Obsessions without Visible Compulsions
- 5.5.1. Global Obsessive Compulsion Disorder Drug Market, by Obsessions without Visible Compulsions, by Region, 2019-2032 (USD Million)
- 5.6. Symmetry Obsessions with ordering compulsions
- 5.6.1. Global Obsessive Compulsion Disorder Drug Market, by Symmetry Obsessions with ordering compulsions, by Region, 2019-2032 (USD Million)
- 5.7. Hoarding
- 5.7.1. Global Obsessive Compulsion Disorder Drug Market, by Hoarding, by Region, 2019-2032 (USD Million)
6. Global Obsessive Compulsion Disorder Drug Market, by Symptoms Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 6.3. Cognitive Behavioural Therapy
- 6.3.1. Global Obsessive Compulsion Disorder Drug Market, by Cognitive Behavioural Therapy, by Region, 2019-2032 (USD Million)
- 6.4. Augmentation Therapy
- 6.4.1. Global Obsessive Compulsion Disorder Drug Market, by Augmentation Therapy, by Region, 2019-2032 (USD Million)
- 6.5. Aversion Therapy
- 6.5.1. Global Obsessive Compulsion Disorder Drug Market, by Aversion Therapy, by Region, 2019-2032 (USD Million)
- 6.6. Systematic Desensitization
- 6.6.1. Global Obsessive Compulsion Disorder Drug Market, by Systematic Desensitization, by Region, 2019-2032 (USD Million)
- 6.7. Others
- 6.7.1. Global Obsessive Compulsion Disorder Drug Market, by Others, by Region, 2019-2032 (USD Million)
7. Global Obsessive Compulsion Disorder Drug Market, by Distribution Channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.3. Hospital Pharmacy
- 7.3.1. Global Obsessive Compulsion Disorder Drug Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Million)
- 7.4. Online Pharmacy
- 7.4.1. Global Obsessive Compulsion Disorder Drug Market, by Online Pharmacy, By Region, 2019-2032 (USD Million)
- 7.5. Drug Store
- 7.5.1. Global Obsessive Compulsion Disorder Drug Market, by Drug Store, By Region, 2019-2032 (USD Million)
- 7.6. Retail Pharmacy
- 7.6.1. Global Obsessive Compulsion Disorder Drug Market, by Retail Pharmacy, By Region, 2019-2032 (USD Million)
8. Global Obsessive Compulsion Disorder Drug Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Obsessive Compulsion Disorder Drug Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Obsessive Compulsion Disorder Drug Market - North America
- 8.3.1. North America: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.3.2. North America: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.3.3. North America: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.3.4. Obsessive Compulsion Disorder Drug Market - U.S.
- 8.3.4.1. U.S.: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.3.5. Obsessive Compulsion Disorder Drug Market - Canada
- 8.3.5.1. Canada: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.4. Obsessive Compulsion Disorder Drug Market - Europe
- 8.4.1. Europe: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.4.2. Europe.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.3. Europe: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.4.4. Obsessive Compulsion Disorder Drug Market - UK
- 8.4.4.1. UK: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.4.3. UK: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.4.5. Obsessive Compulsion Disorder Drug Market - France
- 8.4.5.1. France: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.4.5.2. France.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.5.3. France: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.4.6. Obsessive Compulsion Disorder Drug Market - Germany
- 8.4.6.1. Germany: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.4.7. Obsessive Compulsion Disorder Drug Market - Italy
- 8.4.7.1. Italy: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.4.8. Obsessive Compulsion Disorder Drug Market - Spain
- 8.4.8.1. Spain: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.4.9. Obsessive Compulsion Disorder Drug Market - Netherlands
- 8.4.9.1. Netherlands: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.4.10. Obsessive Compulsion Disorder Drug Market - Russia
- 8.4.10.1. Russia: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.5. Obsessive Compulsion Disorder Drug Market - Asia Pacific
- 8.5.1. Asia Pacific: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.5.4. Obsessive Compulsion Disorder Drug Market - China
- 8.5.4.1. China: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.5.4.2. China.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.4.3. China: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.5.5. Obsessive Compulsion Disorder Drug Market - India
- 8.5.5.1. India: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.5.5.2. India.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.5.3. India: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.5.6. Obsessive Compulsion Disorder Drug Market - Malaysia
- 8.5.6.1. Malaysia: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.5.7. Obsessive Compulsion Disorder Drug Market - Japan
- 8.5.7.1. Japan: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.5.8. Obsessive Compulsion Disorder Drug Market - Indonesia
- 8.5.8.1. Indonesia: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.5.9. Obsessive Compulsion Disorder Drug Market - South Korea
- 8.5.9.1. South Korea: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.6. Obsessive Compulsion Disorder Drug Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.6.4. Obsessive Compulsion Disorder Drug Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.6.5. Obsessive Compulsion Disorder Drug Market - UAE
- 8.6.5.1. UAE: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.6.6. Obsessive Compulsion Disorder Drug Market - Israel
- 8.6.6.1. Israel: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.6.7. Obsessive Compulsion Disorder Drug Market - South Africa
- 8.6.7.1. South Africa: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.7. Obsessive Compulsion Disorder Drug Market - Latin America
- 8.7.1. Latin America: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.3. Latin America: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.7.4. Obsessive Compulsion Disorder Drug Market - Mexico
- 8.7.4.1. Mexico: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.7.5. Obsessive Compulsion Disorder Drug Market - Brazil
- 8.7.5.1. Brazil: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
- 8.7.6. Obsessive Compulsion Disorder Drug Market - Argentina
- 8.7.6.1. Argentina: Obsessive Compulsion Disorder Drug Market, by Therapy Type, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Obsessive Compulsion Disorder Drug Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Obsessive Compulsion Disorder Drug Market, by Symptoms Type, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abbott
- 10.1.1. Company Overview
- 10.1.2. Financial PerSymptoms Typeance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Abbvie Inc
- 10.2.1. Company Overview
- 10.2.2. Financial PerSymptoms Typeance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Addex Pharmaceuticals Ltd
- 10.3.1. Company Overview
- 10.3.2. Financial PerSymptoms Typeance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. AstraZeneca
- 10.4.1. Company Overview
- 10.4.2. Financial PerSymptoms Typeance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Brainsway
- 10.5.1. Company Overview
- 10.5.2. Financial PerSymptoms Typeance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. C4X discovery holdings plc
- 10.6.1. Company Overview
- 10.6.2. Financial PerSymptoms Typeance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Eli Lilly and Company
- 10.7.1. Company Overview
- 10.7.2. Financial PerSymptoms Typeance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. F. Hoffmann-La-Roche Ltd
- 10.8.1. Company Overview
- 10.8.2. Financial PerSymptoms Typeance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Meiji holdings Co. Ltd
- 10.9.1. Company Overview
- 10.9.2. Financial PerSymptoms Typeance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Merck & Co. Inc
- 10.10.1. Company Overview
- 10.10.2. Financial PerSymptoms Typeance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Mylan
- 10.11.1. Company Overview
- 10.11.2. Financial PerSymptoms Typeance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Novartis AG
- 10.12.1. Company Overview
- 10.12.2. Financial PerSymptoms Typeance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Omeros Corporation
- 10.13.1. Company Overview
- 10.13.2. Financial PerSymptoms Typeance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Pfizer Inc
- 10.14.1. Company Overview
- 10.14.2. Financial PerSymptoms Typeance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Sanofi
- 10.15.1. Company Overview
- 10.15.2. Financial PerSymptoms Typeance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
- 10.16. Sellas
- 10.16.1. Company Overview
- 10.16.2. Financial PerSymptoms Typeance
- 10.16.3. Product Benchmarking
- 10.16.4. Recent Development
- 10.17. Zydus Cadila
- 10.17.1. Company Overview
- 10.17.2. Financial PerSymptoms Typeance
- 10.17.3. Product Benchmarking
- 10.17.4. Recent Development